Global Bifurcation Lesions Market to Reach US$ 3.0 Billion by 2027, Stimulated by Rising Incidences of Coronary Artery Disease

December 05, 2022

IMARC Group’s latest report, titled “Bifurcation Lesions Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027,” finds that the global bifurcation lesions market size reached US$ 2.2 Billion in 2021. Bifurcation lesions refer to a condition that occurs when a coronary artery narrows adjacent to and involving the origin of a major side branch. They are caused by plaque deposits comprised of fat. They can be detected via diagnostic imaging techniques, such as computed tomography coronary angiography (CTCA) and invasive coronary angiography (ICA). Some commonly used treatment techniques include analysis, procedure duration, X-ray exposure, and long-term follow-up. Since these lesions increase the risk of heart attacks and stroke in patients, bifurcation lesions treatment solutions are gaining immense traction across the globe.

Global Bifurcation Lesions Market Trends:

The rising incidences of coronary artery disease (CAD) have led to an increased risk of bifurcation lesions, which represents the primary factor driving the market growth. Moreover, the expanding geriatric population that is more prone to developing such medical conditions is acting as another significant growth-inducing factor. In addition, governments of various countries are taking favorable initiatives for reimbursement and insurance coverage. In line with this, the declining risks associated with bifurcation lesions treatment due to the surging number of skilled healthcare professionals have augmented the product demand. Besides this, the shifting consumer preferences toward minimally invasive (MI) procedures have propelled market growth. Furthermore, several key players are heavily investing in ongoing clinical trials on stents and balloons for the treatment of bifurcation lesions. Along with this, recent developments in imaging modalities and advancements in devices, adjunctive pharmacotherapy, and vascular access have facilitated the efficient management of complex bifurcation lesion cases, thereby contributing to market growth. Other factors, including the increasing burden of cardiovascular diseases (CVDs) and obesity, ongoing research on novel treatment techniques, the emerging trend of medical tourism, improving healthcare infrastructure, and rising approval of innovative devices, are also providing a positive thrust to the market growth. Looking forward, IMARC Group expects the market value to reach US$ 3.0 Billion by 2027, growing at a CAGR of 5.5% during 2022-2027.

Market Summary:

  • Based on the types, the market has been classified as one and two stents.
  • On the basis of the application, the market has been bifurcated into coronary and peripheral vascular.
  • Region-wise, the market has been segmented into North America (the United States and Canada), Asia-Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others), Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others), Latin America (Brazil, Mexico, and others), and Middle East and Africa.  
  • The competitive landscape of the market has also been analyzed, with some of the key players being Boston Scientific Corporation, Cardinal Health, Medtronic plc, Spectranetics (Koninklijke Philips N.V.), and Terumo Corporation.
     

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Contact Us:

IMARC Group
30 N Gould St, Ste 
Sheridan, WY (Wyoming) 82801 USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

Global Bifurcation Lesions Market to Reach US$ 3.0 Billion by 2027, Stimulated by Rising Incidences of Coronary Artery Disease
Select Licence Type



Benefits of Customization

Personalize This Research

Triangulate with your Data

Get Data as per your Format and Definition

Gain a Deeper Dive into a Specific Application, Geography, Customer or Competitor

Any level of Personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Bayer AH

It was indeed a great experience to work with IMARC on the assignment on Aqua market. The team had done a fantastic job in terms of what was expected, what was assured and what was the result… the report gave us many insights and market know how which allowed us to work on our strength and define exact strategies…

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More